NEW YORK (GenomeWeb News) — Genomic Health today said that United HealthCare Insurance will cover its Oncotype Dx test for women who have early-stage breast cancer.  
The Oncotype DX analyzes the risk of a recurrence of breast cancer and predicts the chances that chemotherapy will be beneficial. Genomics Health said the test will be covered for claims for services after Jan. 3.
In March 2006 the National Heritage Insurance Company, a Medicare contractor, said it would cover the test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.